Related Experiment Video

Updated: Apr 19, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM

Yang Chong1, Jie Zhang1, Xinzhen Guo1

  • 1Department of Orthopedic Surgery, the First Affiliated Hospital of Harbin Medical University, No. 23, Youzheng St., Nangang District, Harbin, Heilongjiang Prov.150001, China.

Plos One
|December 24, 2014
PubMed

Insights

MicroRNA-503 (miR-503) is down-regulated in osteosarcoma, inhibiting tumor growth and invasion. Restoring miR-503 may offer a new therapeutic strategy for osteosarcoma patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) play critical roles in cancer development.
  • The specific function of miR-503 in osteosarcoma pathogenesis is currently unknown.
  • Understanding miRNA roles is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To investigate the expression and functional role of miR-503 in osteosarcoma.
  • To identify the molecular mechanisms underlying miR-503's function in osteosarcoma.
  • To evaluate miR-503 as a potential therapeutic target for osteosarcoma.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to assess miR-503 and L1CAM expression.
  • Cell proliferation, migration, and invasion assays.
  • Bioinformatic analysis and luciferase reporter assays for target validation.

Main Results:

  • miR-503 was significantly down-regulated in osteosarcoma cell lines and primary tumors.
  • Restoration of miR-503 suppressed osteosarcoma cell proliferation, migration, and invasion.
  • L1CAM was identified as a direct target of miR-503, with inverse correlation in patient tissues.
  • Low miR-503 levels correlated with shorter disease-free survival in osteosarcoma patients.

Conclusions:

  • miR-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM.
  • Down-regulation of miR-503 contributes to osteosarcoma progression.
  • miR-503 holds potential as a diagnostic biomarker and therapeutic agent for osteosarcoma.

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

12.2K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.1K
MicroRNAs01:22

MicroRNAs

12.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K